Cell Viability Assays Market Report 2024: Size, Share, Growth, Trends, Forecast 2033

The new report published by The Business Research Company, titled ""Cell Viability Assays Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the cell viability assays market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The cell viability assays market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

Role Of Cell-Based Therapeutics In Driving The Growth Of The Cell Viability Assays Market
The increasing cell-based therapeutics is expected to propel the growth of the cell viability assay market going forward. Cell-based therapeutics refer to treatments that use living cells to repair or replace damaged tissue, treat diseases, or restore normal function. Cell-based therapeutics are fueled by advances in biotechnology, increasing investment in regenerative medicine, growing acceptance and adoption of cell therapies, and improvements in cell engineering and manufacturing technologies. Cell viability assays support cell-based therapeutics by ensuring the health, functionality, and safety of therapeutic cells, thereby optimizing treatment efficacy and quality control. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, 38 trials were initiated for non-genetically modified cell therapies in Q1 2023, 7 more than the previous quarter, Q4 2022. Therefore, increasing cell-based therapeutics is driving the growth of the cell viability assay market.

Innovative Cell Screening Technologies Revolutionize Drug Discovery
Major companies operating in the cell viability assays market are developing innovative cell screening technologies to improve accuracy and speed up drug discovery. Cell screening technologies enhance cell viability assays by enabling high-throughput, precise, and rapid analysis of cell health and responses, thus optimizing experimental conditions and improving the development of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, introduced CellShepherd, a cutting-edge platform for single-cell analysis. It utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time monitoring. The autonomous system offers precise cell dispensing, co-culturing in sterile conditions, and imaging with brightfield and fluorescent channels. The AI-driven analysis guarantees accurate cell counting and tracking. This user-friendly platform addresses the increasing need for precise single-cell research in biomedical and life science applications.

The cell viability assays market covered in this report is segmented -
1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16014&type=discount

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc. , Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Contents of the report:
1. Executive Summary
2. Cell Viability Assays Market Report Structure
3. Cell Viability Assays Market Trends And Strategies
4. Cell Viability Assays Market - Macro Economic Scenario
5. Cell Viability Assays Market Size And Growth
…..
27. Cell Viability Assays Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.